The global Multiple Sclerosis (MS) Market was valued at USD 21.5 billion in 2023 and is projected to reach USD 39.20 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.8% over the forecast period from 2024 to 2031. The growing prevalence of multiple sclerosis, advancements in treatment options, and rising awareness of early diagnosis are key factors driving market growth.Marke..